Literature DB >> 15808029

Hormone replacement therapy after the menopause--where are we now?

Janice Rymer, David W Sturdee.   

Abstract

Mesh：

Year:  2005        PMID： 15808029      PMCID： PMC1463085     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  27 in total

Review 1.  Can a healthy endothelium influence the cardiovascular effects of hormone replacement therapy?

Authors:  Kwang Kon Koh
Journal:  Int J Cardiol       Date:  2003-01       Impact factor: 4.164

2.  Breast cancer and hormone-replacement therapy: up to general practice to pick up the pieces.

Authors:  Toine Lagro-Janssen; Walter W Rosser; Chris van Weel
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

3.  Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users.

Authors:  Beverley Lawton; Sally Rose; Deborah McLeod; Anthony Dowell
Journal:  BMJ       Date:  2003-10-11

4.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

5.  Local estrogen treatment in patients with urogenital symptoms.

Authors:  V Simunić; I Banović; S Ciglar; L Jeren; D Pavicić Baldani; M Sprem
Journal:  Int J Gynaecol Obstet       Date:  2003-08       Impact factor: 3.561

6.  Cancer recurrence and mortality in women using hormone replacement therapy: meta-analysis.

Authors:  Linda N Meurer; Sarah Lená
Journal:  J Fam Pract       Date:  2002-12       Impact factor: 0.493

7.  Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.

Authors:  Pierre-Yves Scarabin; Emmanuel Oger; Geneviève Plu-Bureau
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

8.  Breast cancer and hormone-replacement therapy in the Million Women Study.

Authors:  Valerie Beral
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

9.  Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.

Authors:  Howard N Hodis; Wendy J Mack; Stanley P Azen; Roger A Lobo; Donna Shoupe; Peter R Mahrer; David P Faxon; Linda Cashin-Hemphill; Miguel E Sanmarco; William J French; Thomas L Shook; Thomas D Gaarder; Anilkumar O Mehra; Ramin Rabbani; Alex Sevanian; Asit B Shil; Mina Torres; K Heiner Vogelbach; Robert H Selzer
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

10.  Estrogen plus progestin and the risk of coronary heart disease.

Authors:  JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.